Dr. Andrew Selzman, M.D
What this data tells you about Dr. Selzman
Dr. Andrew Selzman is an urology physician in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Selzman performed 6,335 Medicare services across 4,059 unique beneficiaries.
Between the years covered by Open Payments, Dr. Selzman received a total of $3,612 from 27 pharmaceutical and/or device companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Selzman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis | 1,482 | $2 | $4 |
| Bladder ultrasound after voiding | 1,409 | $8 | $24 |
| Office visit, established patient (20-29 min) | 1,210 | $64 | $182 |
| Limited ultrasound scan behind abdominal cavity | 407 | $44 | $120 |
| Office visit, established patient (30-39 min) | 356 | $86 | $256 |
| Diagnostic exam of bladder and urethra using an endoscope | 206 | $181 | $488 |
| Electronic assessment of bladder emptying | 183 | $10 | $50 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 174 | $135 | $440 |
| Hospital follow-up visit, moderate complexity | 164 | $64 | $159 |
| Ultrasound scan of pelvic region through rectum | 90 | $113 | $284 |
| Injection, garamycin, gentamicin, up to 80 mg | 86 | $2 | $6 |
| New patient office visit (30-44 min) | 81 | $77 | $226 |
| Drug injection, under skin or into muscle | 79 | $10 | $32 |
| New patient office visit (45-59 min) | 59 | $107 | $336 |
| Initial hospital admission, moderate complexity | 48 | $101 | $262 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $25 | $68 |
| Simple insertion of temporary bladder tube | 32 | $48 | $124 |
| Biopsy of prostate gland | 28 | $159 | $490 |
| Imaging of urinary tract following injection of a contrast agent | 26 | $20 | $48 |
| Injection, tobramycin sulfate, up to 80 mg | 25 | $2 | $8 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 21 | $260 | $646 |
| Shock wave crushing of kidney stones | 18 | $453 | $1,150 |
| Insertion of temporary bladder tube | 18 | $35 | $90 |
| Biopsy of bladder using an endoscope | 16 | $300 | $768 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $327 | $826 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 14 | $559 | $1,392 |
| Insertion of stent in ureter using an endoscope | 12 | $78 | $336 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 12 | $598 | $1,462 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 11 | $26 | $238 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $159 | $390 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Selzman is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Selzman experienced with automated urinalysis?
Does Dr. Selzman receive payments from pharmaceutical companies?
How do Dr. Selzman's costs compare to other urology physicians in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology